- RESEARCH HIGHLIGHT
Combination treatment for immune-mediated HIV remission
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41591-024-00020-6
UPDATES & CORRECTIONS
Correction 02 April 2024: In the version of this Research Highlight originally published, the number of study animals and doses noted were incorrect. The sentence that originally read “Thirteen animals were treated with N-803 (six weekly subcutaneous doses) plus bNAbs (two infusion doses), after which ART was discontinued” has now been corrected, to read “In the second of two macaque studies, sixteen animals were treated with N-803 (six weekly doses) plus bNAbs (three infusion doses), after which ART was discontinued.”